Wednesday, September 02, 2020 8:26:28 AM
Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS
New study posted:
https://clinicaltrials.gov/ct2/show/NCT04536350?term=Aviptadil&draw=2&rank=1
New study posted:
https://clinicaltrials.gov/ct2/show/NCT04536350?term=Aviptadil&draw=2&rank=1
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
